Press Releases Novo Nordisk A/S

Equities

NOVO B

DK0062498333

Market Closed - Nasdaq Copenhagen Other stock markets 11:20:00 2024-06-12 EDT			5-day change	1st Jan Change
989.6 ^DKK	+0.77%		+1.67%	+41.76%

05:25pm	Global markets live: Apple, Oracle, Amazon, Boeing, Tesla...
06-11	Health Care Down as Rally Pauses -- Health Care Roundup	DJ

Press Releases

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Surging Biotech M&A Reaffirms Massive Opportunity In Rare Disease Drug Development (CRDL,JAZZ, NVO, AZN, SNY)	06-11	AQ
Surging Biotech M&A Reaffirms Massive Opportunity In Rare Disease Drug Development	06-11	AQ
Novo Nordisk A/S - share repurchase programme	06-10	GL
Silo Pharma's (NASDAQ: SILO) Promising Developments and Key Insights for Traders and Investors	06-04	AQ
Novo Nordisk A/S - share repurchase programme	06-03	GL
NanoViricides (NNVC) Strengthens Drug Development Efforts with Calvert Labs Partnership and Announces Promising RSV Study Results	05-29	AQ
Novo Nordisk A/S - share repurchase programme	05-27	GL
MAIA Biotechnology (NYSE: MAIA) Makes Strategic Moves: Key Presentations, New Funding, and Leadership Changes Drive Innovation	05-21	AQ
Novo Nordisk A/S - share repurchase programme	05-17	GL
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons	05-15	GL
Novo Nordisk A/S: Once-weekly and once-monthly Mim8 demonstrate superior reduction of treated bleeding episodes compared to on-demand and prior prophylaxis treatment in people with haemophilia A in the Frontier 2 trial	05-13	GL
Tampere University : Novo Nordisk Foundation grants 670 000 EUR to develop organ transplant assessment and drug discovery tool for epilepsy	05-13	AQ
Equity Research \| NANEXA: Insights from CMD underscore near- to mid-term opportunities with significant potential	05-10	AQ
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons	05-08	GL
FORGET HANDBAGS, OZEMPIC'S IN	05-08	AQ
Trading in Novo Nordisk shares by board members, executives and associated persons	05-06	GL
Novo Nordisk A/S - share repurchase programme	05-06	GL
Novo Nordisk A/S purchases B shares worth DKK 5,428 million from Novo Holdings A/S under the 2024 share repurchase programme	05-06	GL
Ventus Therapeutics Announces First Participant Dosed in Clinical Study with an NLRP3 Inhibitor Licensed Exclusively to Novo Nordisk	05-06	AQ
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons	05-03	GL